A detailed history of New Hampshire Trust transactions in Novo Nordisk A S stock. As of the latest transaction made, New Hampshire Trust holds 2,530 shares of NVO stock, worth $215,050. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,530
Previous 2,400 5.42%
Holding current value
$215,050
Previous $343 Million 12.06%
% of portfolio
0.06%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$119.07 - $145.42 $15,479 - $18,904
130 Added 5.42%
2,530 $301 Million
Q3 2023

Oct 17, 2023

BUY
$90.94 - $199.54 $218,256 - $478,896
2,400 New
2,400 $218 Million
Q4 2022

Feb 09, 2023

BUY
$102.55 - $135.33 $123,060 - $162,396
1,200 New
1,200 $162 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track New Hampshire Trust Portfolio

Follow New Hampshire Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Hampshire Trust, based on Form 13F filings with the SEC.

News

Stay updated on New Hampshire Trust with notifications on news.